Developing a fully synthetic, next-generation gene editing technology

Pencil Biosciences is developing a truly innovative gene editing technology that can have an impact across a range of applications, including new therapeutic options for patients with rare diseases

The technology is small, modular in design, and non-CRISPR in composition